Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 procedures
- 31 March 2006
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (2), 186-190
- https://doi.org/10.1016/j.ejso.2005.08.009
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma PeritoneiAnnals of Surgical Oncology, 2004
- Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapyJournal of Surgical Oncology, 2004
- Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosisCancer, 2001
- Unusual origins of pseudomyxoma peritoneiJournal of Surgical Oncology, 2000
- Pseudomyxoma peritoneiBritish Journal of Surgery, 1998
- A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei”The American Journal of Surgical Pathology, 1995
- Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potentialHuman Pathology, 1995
- Pseudomyxoma Peritonei A Cancer Whose Biology Is Characterized by a Redistribution PhenomenonAnnals of Surgery, 1994
- Pseudomyxoma Peritonei Presenting as a Scrotal MassJournal of Urology, 1988
- Pseudomyxoma peritonei associated with colloid carcinoma of the pancreasGastroenterology, 1986